Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma

BACKGROUND: Current standard of treatment for newly diagnosed patients with glioblastoma (GBM) is surgical resection with adjuvant normofractionated radiotherapy (NFRT) combined with temozolomide (TMZ) chemotherapy. Hyperfractionated accelerated radiotherapy (HFRT) which was known as an option from...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Radiat Oncol
Главные авторы: Lewitzki, Victor, Klement, Rainer J., Kosmala, Rebekka, Lisowski, Dominik, Flentje, Michael, Polat, Bülent
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2019
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6909505/
https://ncbi.nlm.nih.gov/pubmed/31831026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1427-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы